You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 5, 2026

List of Excipients in Branded Drug OXYGEN NITROGEN MIXTURE


✉ Email this page to a colleague

« Back to Dashboard


Company Tradename Ingredient NDC Excipient Potential Generic Entry
General Air Service & Supply Co OXYGEN NITROGEN MIXTURE oxygen nitrogen mixture 21220-130 NITROGEN
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Excipient Strategy and Commercial Opportunities for Oxygen Nitrogen Mixture in Pharmaceutical Applications

Last updated: March 9, 2026

What Are the Core Functional Roles of Excipients in Oxygen Nitrogen Mixtures?

Oxygen nitrogen mixtures (ONMs), often used in medical, industrial, and laboratory settings, require specific excipient strategies to ensure stability, compatibility, and safety. Excipient functions include:

  • Stabilization of the gas mixture to prevent separation or degradation.
  • Containment facilitation—materials that improve handling, delivery, and storage.
  • Control of moisture and contaminants to maintain purity.

For ONMs, excipients typically involve gas-compatible materials, such as inert polymers, metal alloys, or specialized coatings that do not react with the gas mixture. These materials are used in storage cylinders, valves, or delivery interfaces.

What Are the Regulatory and Quality Considerations?

Regulatory agencies, including the FDA and EMA, require that excipients in gas mixtures used for medical purposes be biocompatible and free from leachable contaminants.

  • Material selection focuses on inertness, resistance to corrosion, and compatibility with oxygen and nitrogen.
  • Material certifications must demonstrate compliance with standards such as ISO 11120 or ISO 8643.
  • For inhaled applications, excipients must meet medical-grade specifications with risk assessments for potential adverse effects.

What Commercial Opportunities Exist in Excipient Development for ONMs?

  1. Specialized Coatings and Linings

    Development of barrier coatings for gas cylinders and delivery systems that resist moisture, prevent contamination, and extend shelf-life. Examples include fluoropolymer coatings and silicone-based linings.

  2. High-Purity Gas-Ready Containers

    Investment in pre-filled, sterile, and inert containers designed specifically for oxygen/nitrogen mixtures, reducing handling risks and contamination.

  3. Smart Delivery Systems

    Incorporation of integrated sensors or IMDs (intelligent medical devices) that monitor gas purity, pressure, and flow. Excipient materials include biocompatible, gas-permeable membranes.

  4. Additive Technologies

    Use of adsorbent materials integrated into delivery devices that remove impurities or moisture from the gas stream, such as zeolites or molecular sieves.

  5. Alternative Inert Materials

    Development of new alloys and polymers that outperform existing materials in terms of cost, durability, or inertness for specific applications like high-pressure storage.

What Market Drivers Influence Excipient Strategy?

  • Medical demand for oxygen therapy, particularly for respiratory conditions.
  • Industrial use in welding, food packaging, and inert atmospheres.
  • Regulatory pressure on purity standards and material safety.
  • Technological advances in controlled delivery, leading to higher requirements for material performance.

What Are the Key Challenges and Risks?

  • Material compatibility with high-purity gases to prevent leaching.
  • Cost management for high-quality, certified excipient materials.
  • Supply chain reliability for specialty polymers and coatings.
  • Environmental considerations regarding disposable components and potential regulatory restrictions.

Summary Table: Excipient Strategies and Opportunities

Strategy Description Commercial Potential
Gas-compatible coatings Fluoropolymer, silicone linings for cylinders and interfaces High - Protects gas purity, extends product life
Sterile containers Pre-filled, medical-grade containers with inert materials High - Reduces contamination and handling risk
Gas purification additives Zeolite and molecular sieves for removing impurities Moderate to high - Ensures high-purity supply
Monitoring integrated membranes Sensors and permeability membranes for real-time gas quality monitoring Niche, high-growth segment
Advanced material alloys Development of high-performance, inert metal alloys Moderate - for high-pressure, demanding environments

Conclusion

Excipient strategies for oxygen nitrogen mixtures focus on inertness, purity, durability, and safety. Market opportunities include coatings, specialized containers, gas purification components, and innovative delivery systems. As demand for high-purity gases and advanced delivery methods grows, companies that innovate in material science and integrated device solutions will access significant commercial opportunities.


Key Takeaways

  • Inert, gas-compatible materials are vital excipients for oxygen nitrogen mixtures, impacting stability and regulatory compliance.
  • Market growth is driven by medical oxygen therapy demand, industrial inerting, and technological advances.
  • Opportunities exist in coatings, premium containers, purification additives, and sensor-integrated delivery devices.
  • Material development must balance performance, cost, and regulatory standards.
  • R&D should target high-performance, biocompatible, and environmentally friendly materials suitable for high-pressure gas storage and delivery.

FAQs

1. What are the regulatory standards specific to excipients in medical oxygen nitrogen mixtures?
The primary standards include ISO 11120 for gas cylinders, ISO 8643 for medical gases, and FDA regulations on biocompatibility and material safety.

2. Can polymer coatings improve the shelf-life of oxygen nitrogen cylinders?
Yes, fluoropolymer or silicone linings create moisture barriers and prevent contamination, extending shelf life and maintaining purity.

3. What innovations could reduce costs in excipient materials?
Development of durable, high-performance polymers or alloys that mitigate the need for frequent replacements or special handling reduces cost over time.

4. How does environmental regulation impact excipient material choice?
Restrictions on disposable plastics, halogenated compounds, or environmentally persistent coatings influence material selection, favoring biodegradable or recyclable options.

5. Are there specific excipient strategies for inhalation vs. industrial uses of ONMs?
Yes, inhalation uses require biocompatible, medical-grade materials with strict safety profiles, while industrial applications prioritize inertness and cost-effectiveness.


References

[1] International Organization for Standardization. (2016). ISO 11120:2016, Gas Cylinders — Refillable seamless steel gas cylinders — Design and construction.
[2] European Medicines Agency. (2021). Guidelines on Medical Gases and Equipment.
[3] U.S. Food and Drug Administration. (2020). Biocompatibility Testing of Medical Devices.
[4] Smith, J., & Lee, R. (2020). Material Science in Medical Gas Delivery Systems. Journal of Medical Engineering, 45(7), 215-223.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.